Caxton Associates LLP Takes $394,000 Position in Acadia Healthcare Company, Inc. $ACHC

Key Points

• Caxton Associates LLP has acquired a new position in Acadia Healthcare Company, purchasing 13,000 shares valued at approximately $394,000 in the first quarter.
• Several institutional investors have significantly increased their stakes in Acadia Healthcare, with Hawk Ridge Capital raising its position by 437.5% and Citigroup increasing its position by 5,144.2% during the same period.
• Acadia Healthcare has received mixed analyst ratings, with price targets adjusted downwards, suggesting a consensus rating of "Moderate Buy" and an average target price of $39.00.

Caxton Associates LLP bought a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 13,000 shares of the company's stock, valued at approximately $394,000.

A number of other institutional investors also recently modified their holdings of the business. Hawk Ridge Capital Management LP lifted its position in Acadia Healthcare by 437.5% during the first quarter. Hawk Ridge Capital Management LP now owns 2,473,226 shares of the company's stock worth $74,988,000 after purchasing an additional 2,013,126 shares during the period. Citigroup Inc. lifted its position in Acadia Healthcare by 5,144.2% during the first quarter. Citigroup Inc. now owns 2,376,209 shares of the company's stock worth $72,047,000 after purchasing an additional 2,330,898 shares during the period. Maverick Capital Ltd. lifted its position in Acadia Healthcare by 116.3% during the first quarter. Maverick Capital Ltd. now owns 2,246,923 shares of the company's stock worth $68,127,000 after purchasing an additional 1,208,296 shares during the period. Abrams Bison Investments LLC bought a new stake in Acadia Healthcare during the first quarter worth about $55,182,000. Finally, Khrom Capital Management LLC lifted its position in Acadia Healthcare by 26.9% during the first quarter. Khrom Capital Management LLC now owns 1,587,299 shares of the company's stock worth $48,127,000 after purchasing an additional 336,297 shares during the period.

Analyst Ratings Changes

Several research firms recently weighed in on ACHC. UBS Group cut their price objective on shares of Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating for the company in a research report on Thursday, August 7th. Cowen reaffirmed a "buy" rating on shares of Acadia Healthcare in a research report on Thursday, August 7th. Guggenheim dropped their target price on shares of Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating for the company in a report on Thursday, August 7th. Bank of America cut shares of Acadia Healthcare from a "buy" rating to a "neutral" rating and dropped their target price for the stock from $27.00 to $25.00 in a report on Wednesday. Finally, Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Sunday, August 3rd. Eight equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, Acadia Healthcare presently has a consensus rating of "Moderate Buy" and an average target price of $39.00.

Acadia Healthcare Trading Down 2.6%

Shares of NASDAQ ACHC opened at $21.73 on Friday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.32. Acadia Healthcare Company, Inc. has a 52-week low of $17.13 and a 52-week high of $79.82. The stock has a market cap of $2.01 billion, a P/E ratio of 14.39, a price-to-earnings-growth ratio of 4.39 and a beta of 0.89. The firm has a 50 day moving average price of $22.09 and a two-hundred day moving average price of $24.29.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The company had revenue of $869.23 million for the quarter, compared to analysts' expectations of $839.59 million. During the same quarter in the previous year, the firm posted $0.91 earnings per share. Acadia Healthcare's revenue for the quarter was up 9.2% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. As a group, equities analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.